Buyout won’t be far away. We will probably see another one of these announcements in the next fortnight covering Angelmans and Pitt Hopkins.
It’s not like Dr T to use adjectives like compelling. He must of had a momentary rush of excitement.
5 Orphan Drugs is going to be hard to resist. Temperature must be rising in the ACAD boardroom.
Ann: Compelling results for 2591 dose ranging study in PMS model, page-10
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |